Home - Boston Life Sciences Times

LATEST ARTICLES

Medtech

Thermo Fisher Scientific Secures U.S. FDA 510(k) Clearance for EXENT System to Aid in Multiple Myeloma Diagnosis

Life Sciences Times - November 12, 20250

Biotech

BostonGene and Kyoto University Form Research Partnership to Advance Precision Oncology

Life Sciences Times - November 12, 20250

People on the Move

Tandem Diabetes Care Appoints Sandra Beaver to Board of Directors

Life Sciences Times - November 12, 20250

Technology

InterSystems Introduces HealthShare AI Assistant to Enhance Clinical Data Access and Decision-Making

Life Sciences Times - November 12, 20250

Technology

MadeAi Expands AI-Driven Platform with New Tools for GVD and JCA Reporting

Life Sciences Times - November 12, 20250

Public Health

New Research: GLP-1 Therapies Could Reduce U.S. Mortality by 3.5% Over the Next Two Decades

Life Sciences Times - November 11, 20250

Public Health

ByHeart Expands Voluntary Nationwide Recall of Infant Formula as Investigation Continues

Life Sciences Times - November 11, 20250

People on the Move

Rockwell Medical Names Rashad Brown Vice President of Manufacturing and Supply Chain

Life Sciences Times - November 11, 20250

Medtech

Electromedical Products International Expands Access to Alpha-Stim for Veterans with Anxiety, Insomnia, and Pain

Life Sciences Times - November 11, 20250

People on the Move

Veranex Appoints Jose Pablo Morales, M.D., as Chief Medical Officer

Life Sciences Times - November 11, 20250

1...767778...831 Page 77 of 831

Radiology Partners Appoints Former Maryland Gov. Larry Hogan to Board

May 1, 2026

SK Capital Completes Sale of Noramco Group Businesses to Siegfried

May 1, 2026

GoodRx Expands Access to Oral Ozempic for Type 2 Diabetes Patients

May 1, 2026

Seaport Therapeutics Prices Upsized IPO at $18 Per Share

May 1, 2026

Most Popular

Radiology Partners Appoints Former Maryland Gov. Larry Hogan to Board

SK Capital Completes Sale of Noramco Group Businesses to Siegfried

GoodRx Expands Access to Oral Ozempic for Type 2 Diabetes Patients

Seaport Therapeutics Prices Upsized IPO at $18 Per Share

Recent Comments

EDITOR PICKS

Iterative Health Raises $77 Million to Expand Clinical Research Network

Thermo Fisher Opens Bioprocess Design Center in Massachusetts to Speed Biologics Development

Thermo Fisher to Sell Microbiology Unit to Astorg in $1.075 Billion Deal

THIS WEEK'S STORIES

Johnson & Johnson Names Ryan Koors Vice President of Investor Relations

AstraZeneca’s SAPHNELO Approved in U.S. as Self-Injectable Treatment for Lupus

Premier Study Unveils New Tool to Identify High-Risk Pregnancies Earlier

POPULAR CATEGORY

ABOUT US

FOLLOW US